Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

ASSOCIATION OF HLA‐DRw9 WITH MYASTHENIA GRAVIS IN CHINESE

View through CrossRef
SUMMARYHLA phenotypes were studied in 59 Chinese myasthenia gravis (MG) patients. Unfractionated peripheral blood mononuclear cells were used for typing of HLA‐A, B and C, and B‐enriched lymphocytes for HLA‐DR. Seventy‐nine healthy subjects were included as controls. When compared with healthy controls, the patients showed significant increases in HLA‐Bw46 (47·5% versus 14%, χ2= 18·7, P < 0·001), HLA‐DRw9 (59·3% versus 11%, χ2= 35·7, P < 0.001), while HLA‐DR3 was decreased (3·4% versus 32·9%, χ2= 18·2, P < 0.001). Further analysis showed that the primary association was with DRw9 and the increase in Bw46 was secondary to it. Both HLA‐Bw46 and ‐DRw9 were increased in all subgroups except where the age of onset was greater than 40 years. Finally, the HLA‐A2‐Bw46‐DRw9 combination was also significantly increased in patients (25.4% versus 5.1%, χ2= 11.5, P < 0.001), especially in the subgroups of MG with age of onset of less than 10 and males with age of onset of less than 40 years.
Title: ASSOCIATION OF HLA‐DRw9 WITH MYASTHENIA GRAVIS IN CHINESE
Description:
SUMMARYHLA phenotypes were studied in 59 Chinese myasthenia gravis (MG) patients.
Unfractionated peripheral blood mononuclear cells were used for typing of HLA‐A, B and C, and B‐enriched lymphocytes for HLA‐DR.
Seventy‐nine healthy subjects were included as controls.
When compared with healthy controls, the patients showed significant increases in HLA‐Bw46 (47·5% versus 14%, χ2= 18·7, P < 0·001), HLA‐DRw9 (59·3% versus 11%, χ2= 35·7, P < 0.
001), while HLA‐DR3 was decreased (3·4% versus 32·9%, χ2= 18·2, P < 0.
001).
Further analysis showed that the primary association was with DRw9 and the increase in Bw46 was secondary to it.
Both HLA‐Bw46 and ‐DRw9 were increased in all subgroups except where the age of onset was greater than 40 years.
Finally, the HLA‐A2‐Bw46‐DRw9 combination was also significantly increased in patients (25.
4% versus 5.
1%, χ2= 11.
5, P < 0.
001), especially in the subgroups of MG with age of onset of less than 10 and males with age of onset of less than 40 years.

Related Results

High Resolution HLA-A, HLA-B, and HLA-C Allele Frequencies in Romanian Hematopoietic Stem Cell Donors
High Resolution HLA-A, HLA-B, and HLA-C Allele Frequencies in Romanian Hematopoietic Stem Cell Donors
The HLA genes are associated with various autoimmune pathologies, with the control of the immune response also being significant in organs and cells transplantation. The aim of the...
Structural and functional brain alterations in patients with myasthenia gravis
Structural and functional brain alterations in patients with myasthenia gravis
Abstract Myasthenia gravis is an autoimmune disease affecting neuromuscular transmission and causing skeletal muscle weakness. Additionally, systemic inflammation, c...
Diversity of HLA Class I and II Genes in the North Indian Population
Diversity of HLA Class I and II Genes in the North Indian Population
Introduction: Numerous studies have concentrated on specific populations to explore the extensive polymorphism of class I and II HLA genes. This genetic diversity is crucial for va...
KIR-HLA Signal System Genetic Background of Donor and Recipient Determines Outcomes in HLA-Identical Sibling HSCT.
KIR-HLA Signal System Genetic Background of Donor and Recipient Determines Outcomes in HLA-Identical Sibling HSCT.
Abstract Objective: To explore the relationship between the background of donor -recipient KIR-HLA and the outcomes in HLA-identical sibling HSCT in Chinese. ...
Takotsubo syndrome in patients with myasthenia gravis: a systematic review of previously reported cases
Takotsubo syndrome in patients with myasthenia gravis: a systematic review of previously reported cases
Abstract Background Myasthenia gravis associated takotsubo syndrome is a rare condition. This study aimed to explore its typical pres...

Back to Top